Overview
ChatGPT is openai’s flagship conversational AI product, launched in 2022. It supports 900M+ weekly active users and spans consumer, enterprise, and specialized verticals (clinicians, cyber, codex).
Recent Developments
-
2026-07-23: chatgpt-health US rollout; gpt-live desktop voice for Work/Codex (2026-07-24-openai-chatgpt-health-us-rollout, 2026-07-24-openai-gpt-live-codex-desktop-voice)
-
2026-06-29: kaist study found GPT-4o embeds digital-ageism — 60+ portrayed warm but less competent (The Gerontologist, DOI 10.1093/geront/gnaf291) (2026-06-29-kaist-chatgpt-age-bias-study)
-
2026-06-11: Kristie Carrier v. OpenAI — lawsuit alleges ChatGPT failed to intervene during daughter Alice’s 41 documented suicidal ideation mentions over 18 months; GPT-4o engagement design criticized; joins JCCP 5341 coordinated proceeding (2026-06-11-openai-chatgpt-suicide-lawsuit-cbsnews, 2026-06-11-openai-chatgpt-suicide-lawsuit-techjusticelaw)
-
2026-06-04: lockdown-mode expanded to all personal accounts
-
2026-04-20: Global outage affecting millions (infrastructure capacity)
Safety & Liability Context
Carrier complaint alleges ChatGPT mimicked therapist/confidant behavior, validated suicidal thoughts, and discouraged crisis hotline use. OpenAI says involved model version is retired; continues strengthening mental-health safeguards.
Allegations are from plaintiff complaints — not adjudicated findings. Sensitive topic requires responsible editorial framing.